Skip to content
Home/Companies/Healthcare/PulseSight Therapeutics
PT

PulseSight Therapeutics

Healthcare·France·Exited 2019·Held 2yr

PulseSight Therapeutics is a healthcare company, headquartered in France.

Entry
2017
Hold
2yr
Exit
2019
Est. EV
–

Who owns PulseSight Therapeutics?

PulseSight Therapeutics was owned by Karista through CapDecisif 3 (2013 vintage) from 2017 to 2019, exited via MBO.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Karista
Investor
Karista
CapDecisif 3 · 2013 · VC

Key facts

HQFrance
SectorHealthcare
Exit Type
MBO
Buyer
MOIC
–
Exit Year
2019

More from CapDecisif 3

Other portfolio companies in the same fund.

PayinTech
Active
FinancialsFrance· 2017
Actvt
Active
SoftwareFrance· 2016
E(ye)Brain
Active
HealthcareFrance· 2016
Minka Therapeutics
Exited 2022
HealthcareFrance· 2016
to
Nokad
Active
Business ServicesFrance· 2016
Physikron
Exited 2017
HealthcareFrance· 2016
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings